Cancer Immunotherapy in Clinical Practice: Principles and Practice: Principles and Practice Contributor(s): Boyiadzis, Michael M. (Author), Kirkwood, John M. (Author), Whiteside, Theresa L. (Author) |
|
ISBN: 1259642046 ISBN-13: 9781259642043 Publisher: McGraw Hill / Medical OUR PRICE: $160.55 Product Type: Paperback - Other Formats Published: May 2025 This item may be ordered no more than 25 days prior to its publication date of May 6, 2025 |
Additional Information |
BISAC Categories: - Medical | Hematology - Health & Fitness | Diseases - Cancer - Medical | Oncology - General |
Physical Information: 512 pages |
Themes: - Topical - Health & Fitness |
Descriptions, Reviews, Etc. |
Publisher Description: A top-to-bottom overview of cancer immunotherapy-from basic science to clinical application The rapidly evolving field of immunotherapy is thoroughly and expertly covered in this cutting-edge text. Written by a world-renowned author team, this innovative resource provides readers with a solid grasp of the fundamental principles of basic immunology so they can better understand the medical uses of immunotherapy. The book then advances to practical application and toxicity management. Presented in a concise, templated, and easy-to-read format, Cancer Immunotherapy in Clinical Practice is the single-best resource for readers to familiarize themselves with the medical use of immunotherapy. The book includes an entire section on eighteen individual cancer types (brain, breast, etc.) with listings of approved drugs, information on each drug, and discussion of emerging therapies for each of the cancers.
|
Contributor Bio(s): Boyiadzis, Michael: - Michael Boyiadzis, MD is Associate Professor of Medicine, Department of Medicine, Division of Hematology/Oncology, University of Pennsylvania Medical Center Cancer Pavilion. Michael Boyiadzis, MD, Associate Professor of Medicine, Department of Medicine, Division of Hematology/Oncology, UPMC Cancer Pavilion. His area of specialty and interests are: Acute leukemia, development of novel therapies for acute leukemia, natural killer cell biology, immunotherapy, and hematopoietic stem cell transplantation. John M. Kirkwood, MD Usher Professor of Medicine, Dermatology, and Translational Science, Director, Melanoma and Skin Cancer Program, University of Pittsburgh Cancer Institute, Hillman Cancer Center Research Pavilion. Dr. Kirkwood's research focuses on melanoma, a cancer that afflicts more than 60,000 per year and is fatal to nearly 9,000 per year in the United States. He has received international acclaim for pioneering work with immunomodulators for melanoma that provided the first FDA-approved adjuvant therapy of melanoma in 1996. He has led more than 250 trials over the past 31 years evaluating cytotoxic, molecular, and immunomodulator therapies including vaccines for metastatic and high-risk melanoma. Theresa L. Whiteside, PhD, Professor of Pathology, Immunology, & Otolaryngology, Hillman Cancer Center Research Pavilion. Dr. Whiteside is a clinical immunologist with many years of experience in evaluating human immune-mediated diseases. For many years, she directed an immunopathology laboratory performing a broad spectrum of immunodiagnostic assays. Her research expertise is in cellular and molecular cancer immunology. |